The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The negative prognostic impact of downstaging after neoadjuvant chemotherapy in patients with hormone-receptor positive breast cancer.
Yuko Takahashi
No relevant relationships to disclose
Naoki Hayashi
No relevant relationships to disclose
Naoko Matsuda
No relevant relationships to disclose
Yuka Kajiura
No relevant relationships to disclose
Atsushi Yoshida
No relevant relationships to disclose
Hiroshi Yagata
No relevant relationships to disclose
Seigo Nakamura
No relevant relationships to disclose
Koyu Suzuki
No relevant relationships to disclose
Hiroko Tsunoda
No relevant relationships to disclose
Hideko Yamauchi
No relevant relationships to disclose